Sign in
Taking peopleNo phase

Shadow-Mode Evaluation of an AI Assistant for Multidisciplinary Tumor Boards

Key facts

Who runs it
Technical University of Munich
Where
Germany2 sites in 1 countryChoose a country to see its sites
Trial code
Status
Recruiting
People taking part
450 people, planned
Started
9 Nov 2026
Expected to end
30 Apr 2027
Type of study
Observational, 3 groups
Treatments tested
  • OnkoBot (shadow mode)
Record updated
16 November 2026

Who can take part

Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 4 criteriaShow less

Who can take part

  • Case registered for a session of a participating tumor board (hematology, orthopedics and sarcoma, head and neck) of TUM University Hospital rechts der Isar during the study period
  • Board registration and pre-board patient documents available before the session starts

Who cannot take part

  • Case not discussed at the session, defined as no board report with a consensus decision for that date (deferred or withdrawn registrations)
  • Session without a shadow run of the system; Excluded cases are counted and reported by reason

This trial has no sites in United States.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

This study tests whether an artificial intelligence (AI) system that drafts tumor board recommendations performs as well on new cases as it did on archived cases. The system runs in shadow mode at three multidisciplinary tumor boards of TUM University Hospital rechts der Isar. For each case it drafts a recommendation before the board meets. The board does not see the draft, and the draft has no influence on patient care. After the meeting, each draft is compared with the board decision. The agreement rate is then compared with the rate measured on archived decisions of the same boards.

The 3 groups in the trial

  • Hematology board

    Consecutive cases presented at the hematology tumor board of TUM University Hospital rechts der Isar.

    Treatment: OnkoBot (shadow mode)

  • Orthopedics and sarcoma board

    Consecutive cases presented at the orthopedics and sarcoma tumor board of TUM University Hospital rechts der Isar.

    Treatment: OnkoBot (shadow mode)

  • Head and neck board

    Consecutive cases presented at the head and neck tumor board of TUM University Hospital rechts der Isar.

    Treatment: OnkoBot (shadow mode)

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
OnkoBot: Prospective Shadow-Mode Evaluation of a Locally Operated, Source-Grounded Large Language Model System for Drafting Multidisciplinary Tumor Board Recommendations
Record updated
16 November 2026